A Single Oral Dose of Thalidomide Enhances the Capacity of Lymphocytes to Secrete Gamma Interferon in Healthy Humans

Thalidomide is increasingly being used as adjuvant therapy for patients with mycobacterial and human immunodeficiency virus (HIV) infections. The T-helper (Th)1 cytokine–Th2 cytokine balance critically determines the outcomes of these diseases. To obtain insight into the effect of thalidomide on the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Verbon, Annelies, Juffermans, Nicole P., Speelman, Peter, van Deventer, Sander J. H., ten Berge, Ineke J. M., Guchelaar, Henk-Jan, van der Poll, Tom
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2000
Matèries:
Biologic Response Modifiers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC90059/
https://ncbi.nlm.nih.gov/pubmed/10952569
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars